HUM - Humana stock slides after cutting annual earnings outlook
2024-01-18 07:04:14 ET
Humana ( NYSE: HUM ) shares dipped 11% premarket on Thursday after the health insurer revised its annual profit outlook citing higher-than-expected medical costs.
The company now expects $26.09 in adjusted earnings per common share for the year ended December 31, 2023 compared to previous guidance of at least $28.25. Analysts expect Humana ( HUM ) to earn $28.30 a share in the year.
"The company anticipated the higher level of medical utilization experienced during the third quarter in its Medicare Advantage business would continue for the remainder of the year. Actual fourth quarter results reflect an additional increase in Medicare Advantage medical cost trends, driven by higher than anticipated inpatient utilization, primarily for the months of November and December, as well as a further increase in non-inpatient trends," said the company in a filing .
The Louisville, Kentucky-based firm is currently assessing the expected impact of emerging utilization trends on its 2024 outlook, which is anticipated to be material if current trends continue, and will provide an update on its fourth quarter 2023 earnings call, which has been rescheduled for January 25th, 2024.
"Humana believes the emerging trends are impacting the industry broadly and anticipates the trends will be contemplated in the 2025 Medicare Advantage pricing cycle," the company added.
For 2024, the insurer expects individual Medicare Advantage growth of ~100,000 members, representing 1.8% growth over its membership as of December 31, 2023 of approximately 5.4Mmembers, compared to its previous commentary of 'at or slightly above industry average growth.'
More on Humana
- Humana: My Oh My, Another Strong Buy
- Humana: Buy This Powerful Dividend Growth Stock In The New Year
- Humana: Failed Merger And Other Reasons To Buy
- Health insurers face deadlines for prior authorization requests
- Walgreens reaches $360M settlement with Humana in drug-pricing dispute
For further details see:
Humana stock slides after cutting annual earnings outlook